Aurinia Pharmaceuticals
AUPH
$4.99
Share price
3.74%
Change (1 day)
-54.64%
Change (1 year)
Categories
Market capitalization of Aurinia Pharmaceuticals (AUPH)
Market cap: $0.72 Billion
As of April 2024 Aurinia Pharmaceuticals has a market cap of $0.72 Billion. This makes Aurinia Pharmaceuticals the world's 5510th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Aurinia Pharmaceuticals from 2009 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.72 B | -44.1% |
| 2023 | $1.29 B | 110.3% |
| 2022 | $0.61 B | -79.3% |
| 2021 | $2.96 B | 70.15% |
| 2020 | $1.74 B | -22.54% |
| 2019 | $2.25 B | 286.25% |
| 2018 | $0.58 B | 52.27% |
| 2017 | $0.38 B | 358.79% |
| 2016 | $83.38 M | 2.99% |
| 2015 | $80.96 M | -28.82% |
| 2014 | $0.11 B | 149.67% |
| 2013 | $45.55 M | 327.26% |
| 2012 | $10.66 M | -47.84% |
| 2011 | $20.44 M | -49.61% |
| 2010 | $40.56 M | 96.05% |
| 2009 | $20.69 M |
End of Day market cap according to different sources
On Apr 19th, 2024 the market cap of Aurinia Pharmaceuticals was reported to be:
$0.72 Billion
$0.72 Billion
$0.72 Billion
$0.72 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $98.43 B | 13,540.63% | 🇺🇸 USA |
 Pieris Pharmaceuticals PIRS | $14.34 M | -98.01% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $9.46 M | -98.69% | 🇺🇸 USA |